3Smith T,Gildeh N,Holmes C,et al.The Montreal Cognitive As-sessment:Validity and Utility in a Memory Clinic Setting.Can J Psy-chiatry,2007,52(5):329.
4Bertram L,Hiltumen M,Parkinson M,et al.Family -based associa-tion between Alzheimer 's disease and variants in UBPLIN1.N Engl J Med,2005,352:884.
5Bertram L,Hiltumen M,Parkinson M.Family-based association be-tween Alzheimer 's disease and variants in UBPLIN1.N Engl J Med,2005,352:884.
6Bertram L,McQueen MB,Mullin K,et al.Systematic meta -analy-ses of Alzheimer disease.Nat Genet,2007,39(1):17.
7Mulder C,Scheltens P,Visser J J,et al.Genetic and biochemical markers for Alzheimer 's disease:recent developments.Ann Clin Biochem,2000,37:593.
8Flier WM,Staekenborg S,Pijnenburg YA,et al.Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease.Dement Geriatr Cogn Disord,2007,23(1):42.
9Williamson J,Goldman J,Marder KS.Genetic aspects of Alzheimer disease.Neurologist,2009,15(2):80.
10Bemardini S,Bellincampi L,Ballerini S,et al.Glutathione S -Transferase P1 *C Allelic Variant Increases Susceptibility for Late-Onset Alzheimer Disease:Association Study and Relationship with Apolipoprotein E ε 4 Allele.Clinical Chemistry,2005,51(6):944.
